701910-30-7

Basic information

• Product Name: 7-Bromo-2-methyl-2H-indazole-3-carboxylic acid
• Synonyms: 7-Bromo-2-methyl-2H-indazole-3-carboxylic acid
• CAS NO: 701910-30-7
• Molecular Formula: C9H7BrN2O2
• Molecular Weight: 255.07
• Mol File: 701910-30-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 468.4°C at 760 mmHg
• Flash Point: 237.1°C
• Appearance: /
• Density: 1.79g/cm³
• Vapor Pressure: 1.41E-09mmHg at 25°C
• Refractive Index: 1.7
• CAS DataBase Reference: 7-Bromo-2-methyl-2H-indazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Bromo-2-methyl-2H-indazole-3-carboxylic acid(701910-30-7)
• EPA Substance Registry System: 7-Bromo-2-methyl-2H-indazole-3-carboxylic acid(701910-30-7)

Safety Data

• Hazardous Substances Data: 701910-30-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H7BrN2O2/c1-12-8(9(13)14)5-3-2-4-6(10)7(5)11-12/h2-4H,1H3,(H,13,14)

Upstream product

• 701910-34-1 methyl 7-bromo-2-methylindazole-3-carboxylate 
• 701910-14-7 7-bromo-2-methyl-2H-indazole 
• 53857-58-2 7-bromo-1H-indazole 

Relevant articles and documents

GABANERGIC MODULATORS

This invention relates to the use of compounds of benzoindazole derivatives salts and solvates thereof for the preparation of a medicament for modulating alpha2 subtype GABA A receptors. The invention further relates to novel heterocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the use of compounds of formula (I) salts and solvates thereof for the preparation of a medicament for the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain.